Tricia Jarin's Colleagues at ALX Oncology
Tricia Jarin's Contact Details
HQ
["(353) 161-8000"]
["(353) 161-8000"]
Location
Company
ALX Oncology
ALX Oncology
Tricia Jarin's Company Details
ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system. ALX Oncology's lead product candidate, evorpacept (also known as ALX148), is a next generation CD47 blocking therapeutic that combines a high-affinity CD47 binding domain with an inactivated, proprietary Fc domain. Evorpacept has demonstrated promising clinical responses across a range of hematologic and solid malignancies in combination with a number of leading anti-cancer agents.
Frequently Asked Questions about Tricia Jarin
Tricia Jarin currently works for ALX Oncology.
Tricia Jarin's role at ALX Oncology is .
Tricia Jarin's email address is ***@alxoncology.com. To view Tricia Jarin's full email address, please signup to ConnectPlex.
Tricia Jarin works in the Research industry.
Tricia Jarin's colleagues at ALX Oncology are Isaac Blum, Shaira Tumaneng, Selina Lau, Julie Bacon, Jaume Pons, Mithu Sherin, Sophia Randolph and others.
Tricia Jarin's phone number is ["(353) 161-8000"]